| Structure |
Chemical Name |
CAS |
MF |
 |
SU 11274 |
658084-23-2 |
C28H30ClN5O4S |
 |
Linsitinib |
867160-71-2 |
C26H23N5O |
 |
J&J Ex-61 |
943540-75-8 |
C19H13F2N7 |
 |
Orantinib (SU6668) |
252916-29-3 |
C18H18N2O3 |
 |
Cabozantinib Malate |
1140909-48-3 |
C32H30FN3O10 |
![1-Cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](/CAS2/GIF/1092788-83-4.gif) |
1-Cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
1092788-83-4 |
C17H17N7 |
 |
PD04217903 |
956905-27-4 |
C19H16N8O |
 |
TYRPHOSTIN AG 879 |
148741-30-4 |
C18H24N2OS |
![N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide](/CAS2/GIF/875337-44-3.gif) |
N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide |
875337-44-3 |
C26H20FN5O2S2 |
 |
SGX-523 |
1022150-57-7 |
C18H13N7S |
 |
AZD8931 |
848942-61-0 |
C23H25ClFN5O3 |
 |
Apatinib |
811803-05-1 |
C24H23N5O |
 |
Crenolanib |
670220-88-9 |
C26H29N5O2 |
 |
AC480 (BMS-599626) |
714971-09-2 |
C27H27FN8O3 |
 |
TYRPHOSTIN AG 1296 |
146535-11-7 |
C16H14N2O2 |
 |
GW441756 |
504433-23-2 |
C17H13N3O |
 |
AMG-706 |
857876-30-3 |
C22H29N5O9P2 |
 |
AP26113 |
1197958-12-5 |
C26H34ClN6O2P |
 |
Desvenlafaxine succinate |
386750-22-7 |
C20H31NO6 |
 |
AEE788 |
497839-62-0 |
C27H32N6 |
![3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide](/CAS/GIF/1009298-59-2.gif) |
3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide |
1009298-59-2 |
C25H30N6O3 |
 |
SUCCINYLCHOLINE CHLORIDE DIHYDRATE |
6101-15-1 |
C14H34Cl2N2O6 |
 |
Bromfenac sodium |
91714-93-1 |
C15H11BrNNaO3 |
![N-(2,3-Dihydro-7,8-dimethoxyimidazo[1,2-c]quinazolin-5-yl)-3-pyridinecarboxamide](/CAS/GIF/677338-12-4.gif) |
N-(2,3-Dihydro-7,8-dimethoxyimidazo[1,2-c]quinazolin-5-yl)-3-pyridinecarboxamide |
677338-12-4 |
C18H17N5O3 |
 |
(R)-5-HydroxyMethyl Tolterodine |
207679-81-0 |
C22H31NO2 |
 |
Vatalanib Dihydrochloride |
212141-51-0 |
C20H17Cl3N4 |
 |
1,2-Diaminoethan |
107-15-3 |
C2H8N2 |
 |
NAFAMOSTAT MESYLATE |
81525-10-2 |
C19H17N5O2 |
 |
Azathioprin |
446-86-6 |
C9H7N7O2S |
 |
PIK-93 |
593960-11-3 |
C14H16ClN3O4S2 |
![6-Amino-N-[3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenyl]-3-pyridinecarboxamide](/CAS2/GIF/371942-69-7.gif) |
6-Amino-N-[3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenyl]-3-pyridinecarboxamide |
371942-69-7 |
C25H21N7O3 |
 |
GSK-3BETA INHIBITOR XII |
601514-19-6 |
C18H14N4O2 |
 |
PF-05212384 |
1197160-78-3 |
C32H41N9O4 |
 |
IPI 145 |
1201438-56-3 |
C22H17ClN6O |
 |
Prucalopride Succinate |
179474-85-2 |
C22H32ClN3O7 |
 |
OSI-027 |
936890-98-1 |
C21H22N6O3 |
 |
AG 1478 HYDROCHLORIDE |
153436-53-4 |
C16H14ClN3O2 |
 |
SB271046 |
209481-20-9 |
C20H22ClN3O3S2 |
 |
PaloMid 529 (P529) |
914913-88-5 |
C24H22O6 |
 |
GSK2636771 |
1372540-25-4 |
C22H22F3N3O3 |
 |
BIO |
667463-62-9 |
C16H10BrN3O2 |
 |
Ki8751 |
228559-41-9 |
C24H18F3N3O4 |
![(2R)-1-[[5-[(Z)-[5-[[(2,6-DICHLOROPHENYL)METHYL]SULFONYL]-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE]METHYL]-2,4-DIMETHYL-1H-PYRROL-3-YL]CARBONYL]-2-(1-PYRROLIDINYLMETHYL)PYRROLIDINE](/CAS/GIF/477575-56-7.gif) |
(2R)-1-[[5-[(Z)-[5-[[(2,6-DICHLOROPHENYL)METHYL]SULFONYL]-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE]METHYL]-2,4-DIMETHYL-1H-PYRROL-3-YL]CARBONYL]-2-(1-PYRROLIDINYLMETHYL)PYRROLIDINE |
477575-56-7 |
C32H34Cl2N4O4S |
 |
42-(Dimethylphosphinate)rapamycin |
572924-54-0 |
C53H84NO14P |
 |
LY2886721 |
1262036-50-9 |
C18H16F2N4O2S |
 |
Indacaterol Maleate |
753498-25-8 |
C24H28N2O3.C4H4O4 |
 |
BMY 7378 DIHYDROCHLORIDE |
21102-95-4 |
C22H32ClN3O3 |
 |
4-BENZYL-2-METHYL-1,2,4-THIADIAZOLIDINE-3,5-DIONE |
327036-89-5 |
C10H10N2O2S |
 |
ROTIGOTINE |
99755-59-6 |
C19H25NOS |
 |
Aclidinium bromide |
320345-99-1 |
C13H10BrN |
![5-[[5-(4-Fluoro-2-hydroxyphenyl)-2-furanyl]methylene]-2,4-thiazolidinedione](/CAS/GIF/900515-16-4.gif) |
5-[[5-(4-Fluoro-2-hydroxyphenyl)-2-furanyl]methylene]-2,4-thiazolidinedione |
900515-16-4 |
C14H8FNO4S |
![4-Benzyl-1-[β,4-dihydroxy-α-methylphenethyl]piperidiniumhydrogentartrat](/CAS/GIF/23210-58-4.gif) |
4-Benzyl-1-[β,4-dihydroxy-α-methylphenethyl]piperidiniumhydrogentartrat |
23210-58-4 |
C25H33NO8 |
 |
AR-A014418 |
487021-52-3 |
C12H12N4O4S |
 |
JTC 801 |
244218-51-7 |
C26H25N3O2.ClH |
 |
PHA-680632 |
398493-79-3 |
C28H35N7O2 |
 |
MC1568 |
852475-26-4 |
C17H15FN2O3 |
 |
PF 3845 |
1196109-52-0 |
C24H23F3N4O2 |
 |
Ganetespib |
888216-25-9 |
C20H20N4O3 |
 |
M344 |
251456-60-7 |
C16H25N3O3 |
 |
Lomeguatrib |
192441-08-0 |
C10H8BrN5OS |
![N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydro-3-pyridinecarboxamide](/CAS2/GIF/864082-47-3.gif) |
N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydro-3-pyridinecarboxamide |
864082-47-3 |
C21H16F4N4O2 |
 |
CUDC-101 |
1012054-59-9 |
C24H26N4O4 |
 |
CRA-02478 |
783355-60-2 |
C21H23N3O5 |
 |
Volasertib (BI 6727) |
755038-65-4 |
C34H50N8O3 |
 |
LY2811376 |
1194044-20-6 |
C15H14F2N4S |
 |
FLAVOPIRIDOL HYDROCHLORIDE |
131740-09-5 |
C21H21Cl2NO5 |
 |
DARAPLADIB |
356057-34-6 |
C36H38F4N4O2S |
 |
MRS 2578 |
711019-86-2 |
C20H20N6S4 |
 |
OSU-03012 |
742112-33-0 |
C26H19F3N4O |
 |
PF-4708671 |
1255517-76-0 |
C19H21F3N6 |
 |
AT7867 |
857531-00-1 |
C20H20ClN3 |
 |
LONAFARNIB |
193275-84-2 |
C27H31Br2ClN4O2 |
![(1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18,21-tetrazabicyclo[8.7.6]tricos-11-ene-2,5,8,19,22-pentone](/CAS/GIF/128517-07-7.gif) |
(1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18,21-tetrazabicyclo[8.7.6]tricos-11-ene-2,5,8,19,22-pentone |
128517-07-7 |
C24H36N4O6S2 |
 |
Pracinostat |
929016-96-6 |
C20H30N4O2 |
 |
17-DMAG |
467214-21-7 |
C32H49ClN4O8 |
 |
Avasimibe |
166518-60-1 |
C29H43NO4S |
![[4-Amino-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrimidin-5-yl](2,3-difluoro-6-methoxyphenyl)methanone(R 547)](/CAS/GIF/741713-40-6.gif) |
[4-Amino-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrimidin-5-yl](2,3-difluoro-6-methoxyphenyl)methanone(R 547) |
741713-40-6 |
C18H21F2N5O4S |
 |
DGAT-1 inhibitor |
959122-11-3 |
C26H24N2O4 |
 |
GSK1070916 |
942918-07-2 |
C30H33N7O |
![(2R,3R,4S,5R)-2-(6-aMino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]iMidazol-2-yl)ethyl)cyclobutyl)(isopropyl)aMino)Methyl)tetrahydrofuran-3,4-diol](/CAS/20150408/GIF/1380288-87-8.gif) |
(2R,3R,4S,5R)-2-(6-aMino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]iMidazol-2-yl)ethyl)cyclobutyl)(isopropyl)aMino)Methyl)tetrahydrofuran-3,4-diol |
1380288-87-8 |
C30H42N8O3 |
 |
ZEBULARINE |
3690-10-6 |
C9H12N2O5 |
 |
PHA-793887 |
718630-59-2 |
C19H31N5O2 |
 |
SB 743921 |
940929-33-9 |
C31H34Cl2N2O3 |
 |
GDC-0068 |
1001264-89-6 |
C24H32ClN5O2 |
 |
RVX-208 |
1044870-39-4 |
C20H22N2O5 |
 |
N-cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-Methyl-1H-iMidazol-1-yl)acetaMido)-2-(o-tolyl)acetaMide |
1355326-35-0 |
C27H31FN4O2 |
 |
Tipifarnib |
192185-72-1 |
C27H22Cl2N4O |
 |
U-73122 |
112648-68-7 |
C29H40N2O3 |
 |
JNJ-7706621 |
443797-96-4 |
C15H12F2N6O3S |
 |
Cobicistat |
1004316-88-4 |
C40H53N7O5S2 |
 |
Epothilone A |
152044-53-6 |
C26H39NO6S |
 |
S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide |
1346574-57-9 |
C31H38N6O2 |
 |
LY-2484595 |
1186486-62-3 |
C31H36F6N6O2 |
 |
Y27632 (hydrochloride) |
129830-38-2 |
C14H23Cl2N3O |
 |
ACY-1215 |
1316214-52-4 |
C24H27N5O3 |
 |
2-(4-broMo-2-chlorophenoxy)-N-(4-(N-(4,6-diMethylpyriMidin-2-yl)sulfaMoyl)phenylcarbaMothioyl)acetaMide |
587841-73-4 |
C21H19BrClN5O4S2 |
 |
ZM 447439 |
331771-20-1 |
C29H31N5O4 |
 |
N-(5-CHLORO-2,4-DIMETHOXYPHENYL)-N'-(5-METHYL-3-ISOXAZOLYL)-UREA |
501925-31-1 |
C13H14ClN3O4 |
 |
BX-912 |
702674-56-4 |
C20H23BrN8O |
 |
I-BET151 (GSK1210151A) |
1300031-49-5 |
C23H21N5O3 |